1 February 2021 in Radiology
Thrombus enhancement can be used to predict cardioembolic and cryptogenic strokes and to identify thrombus enhancement–positive thrombi, which have a higher fibrin-to-platelet fraction and a lower ... Background Thrombus enhancement (TE) in large vessel occlusion in patients with acute ischemic stroke can be visualized with thin-slab maximum intensity projection (TS-MIP) image reconstruction of ...
9 August 2012 in La radiologia medica
1 May 2015 in Journal of Cardiovascular Computed Tomography
1 September 2015 in Acta Radiologica
Intravenous administration of recombinant tissue plasminogen activator (rtPA) is approved treatment for acute ischemic stroke <3 h of symptom onset. To determine the impact of the timing and degree of recanalization on clinical outcome after rtPA infusion in patients. Seventy-five patients with ischemic stroke in the middle cerebral artery territory treated with intravenous rtPA within 3 h were studied consecutively. Magnetic resonance imaging (MRI), including magnetic resonance angiography (MRA), before, 6 h, and 24 h after thrombolytic therapy was undertaken. Depending on the MRA results acquired 6 h after rtPA infusion, recanalization was graded as: early recanalization (ER), delayed recanalization (DR), and no recanalization (NR). Clinical outcome was assessed using the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS). Of patients in the ER, DR and NR groups, 71.4% (15/21), 13.3% (2/15), and 30.7% (12/39), respectively, showed dramatic improvement in NIHSS score 7 days after rtPA administration compared with those scores upon hospital admission. The 6-h and 24-h NIHSS scores and 3-month mRS scores of ER patients were significantly lower than those of the other two groups (P < 0.05). The 24-h, 7-d NHISS and mRS scores of DR patients were significantly higher than NR patients (P = 0.001, 0.002, 0.049, respectively). Three patients in the DR group died during follow-up. These data suggest that DR is associated with clinical deterioration. Patients treated with rtPA thrombolysis should be under close observation for 6–24 h. Corresponding treatment should be considered once DR appears.
1 August 2023 in Journal of Interventional Medicine
To evaluate the efficacy of stent-assisted coiling (SAC) for the treatment of carotid ophthalmic segment aneurysm segment aneurysms (OSAs) of the internal carotid artery (ICA) through detailed long-term follow-up of a large patient cohort. We retrospectively analyzed 88 consecutive patients with OSAs between January 2009 and January 2020 at our center. Angiographic results were evaluated using the modified Raymond grading system and clinical outcomes were evaluated using the mRS scale. The primary endpoints were major aneurysm recurrence and poor clinical outcomes for at least 18 months of follow-up. The patients were asked to attend clinical follow-up assessments and possibly undergo DSA or MR via telephone. We enrolled 88 patients with 99 OSAs treated with coiling, of whom 76 were treated with SAC. The coiling procedures were successful in all 88 patients. Overall, complications occurred in 8 patients (9.1%). No procedure-related mortality was observed. 67 (76.1%) experienced immediate aneurysm occlusion at the end of the procedure. Long-term angiographic follow-up (18 months) was available in 45/88 aneurysms (51%) (average 18.7 ± 5.2 months). Four patients continued their follow-up for 5 years after initial aneurysm treatment. After a clinical follow-up time of 28.7 months (range, 12–51 months), 85 patients (95.5%) achieved favorable clinical outcomes (mRS scores of 0–2). This study indicates that SAC treatment is a safe and effective therapeutic alternative for ruptured and unruptured OSAs. The procedural risks are low with relatively long-term effectiveness.
1 May 2015 in Neurosurgery Quarterly
Objects: We retrospectively investigated the radiologic differences in subtypes of fusiform aneurysms (FA) of vertebral and basilar arteries. Methods: The study included 37 patients with 39 nonperipheral posterior circulation FAs detected by 3D-TOF-magnetic resonance angiography or by digital subtract angiography. Patient-specific and aneurysm-specific data were summarized. FAs were divided into 3 subtypes: focal FA (type I); classic dissecting aneurysm (type II); and dolichoectatic aneurysm (type III). Correlations between the subtypes and their angiographic features, including location, size, and rupture or not were analyzed. Results: Thirty-nine posterior FAs, including 28 aneurysms located at vertebral artery (VA), 8 at basilar artery (BA) and 3 at vertebrobasilar junction area, were detected in 37 patients. Twenty-one aneurysms in VA and 1 in BA were type II, among them 15 in VA and 1 in BA were ruptured. Focal FAs, including 7 in VA, 6 in BA, and 3 in vertebrobasilar junction area, were type I. One aneurysm in BA was type III. The subtypes of FAs were location specific (P=0.002). Ruptured FAs seemed closely associated with intracranial segment of VA (P=0.037). Conclusions: The subtypes of FAs were location specific, whereas ruptured FAs were mainly type II at VA without correlation with aneurysmal size.